• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-20a 在前列腺癌组织中的表达的重要性。

Importance of miR-20a expression in prostate cancer tissue.

机构信息

Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University in Prague, University Hospital in Pilsen, Czech Republic.

出版信息

Anticancer Res. 2010 Sep;30(9):3579-83.

PMID:20944140
Abstract

BACKGROUND

MicroRNAs (miRNAs), which are endogenously expressed regulatory noncoding RNAs, have an altered expression in tumor tissues. MiRNAs regulate cancer-related processes such as cell growth and tissue differentiation, and therefore, might function as oncogenes or tumor-suppressor genes. The aim of our study was to assess the expression of mir-20a, let-7a, miR-15a and miR-16 in prostate cancer (PCa) and benign prostatic hyperplasia (BPH) tissue and to investigate the relation between the expression of miRNAs and the clinicopathological features of PCa.

PATIENTS AND METHODS

The study group comprised 138 patients: 85 patients with BPH and 53 patients with PCa. The total RNA was isolated from the tissue specimen core and miRNA expressions were quantified using a real-time RT-PCR method (TaqMan MicroRNA Assays). U6snRNA was used for the normalization of the miRNA expression.

RESULTS

miR-20a expression was significantly higher in the group of patients with a Gleason score of 7-10 in comparison with the group of patients with a Gleason score of 0-6 (p=0.0082). We found no statistical differences in the miRNA expressions (mir-20a, let-7a, miR-15a and miR-16) in the PCa tissue samples in comparison with the BPH tissue samples.

CONCLUSION

Our result shows that the more dedifferentiated PCa cells have a higher expression of miR-20a and this supports the oncogenic role of miR-20a in PCa carcinogenesis. The evaluation of miRNA expression could yield new information about PCa pathogenesis.

摘要

背景

微小 RNA(miRNA)是内源性表达的调节性非编码 RNA,在肿瘤组织中表达异常。miRNA 调节与癌症相关的过程,如细胞生长和组织分化,因此可能作为癌基因或肿瘤抑制基因发挥作用。我们的研究目的是评估 mir-20a、let-7a、miR-15a 和 miR-16 在前列腺癌(PCa)和良性前列腺增生(BPH)组织中的表达,并探讨 miRNA 的表达与 PCa 临床病理特征之间的关系。

患者和方法

研究组包括 138 名患者:85 名 BPH 患者和 53 名 PCa 患者。从组织标本核心中分离总 RNA,并使用实时 RT-PCR 方法(TaqMan MicroRNA 测定)定量 miRNA 表达。U6snRNA 用于 miRNA 表达的归一化。

结果

与 Gleason 评分 0-6 组相比,Gleason 评分 7-10 组患者的 miR-20a 表达显著升高(p=0.0082)。我们发现 PCa 组织样本与 BPH 组织样本之间 miRNA 表达(mir-20a、let-7a、miR-15a 和 miR-16)没有统计学差异。

结论

我们的结果表明,分化程度较低的 PCa 细胞 miR-20a 的表达较高,这支持 miR-20a 在 PCa 发生中的致癌作用。miRNA 表达的评估可能为 PCa 发病机制提供新的信息。

相似文献

1
Importance of miR-20a expression in prostate cancer tissue.miR-20a 在前列腺癌组织中的表达的重要性。
Anticancer Res. 2010 Sep;30(9):3579-83.
2
Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.血清 miR-15a 和 miR-16-1 表达在埃及前列腺癌患者中的诊断和预后价值。
IUBMB Life. 2018 May;70(5):437-444. doi: 10.1002/iub.1733. Epub 2018 Mar 9.
3
Detection of miRNAs in urine of prostate cancer patients.前列腺癌患者尿液中微小RNA的检测
Medicina (Kaunas). 2016;52(2):116-24. doi: 10.1016/j.medici.2016.02.007. Epub 2016 Mar 11.
4
MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.外周血单个核细胞中的MicroRNA-21作为前列腺癌诊断和预后的新型生物标志物
Cancer Biomark. 2016 Jul 8;17(2):223-30. doi: 10.3233/CBM-160634.
5
Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.循环 miRNA 作为良性前列腺增生患者前列腺癌诊断的生物标志物。
J Immunol Res. 2020 May 8;2020:5873056. doi: 10.1155/2020/5873056. eCollection 2020.
6
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
7
Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer.循环miR-20a和miR-26a作为前列腺癌的生物标志物
Asian Pac J Cancer Prev. 2019 May 25;20(5):1453-1456. doi: 10.31557/APJCP.2019.20.5.1453.
8
Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.基于血液的前列腺良性增生与前列腺癌的鉴别诊断:miRNA作为独立于PSA水平、Gleason评分或TNM分期的生物标志物来源
Tumour Biol. 2016 Aug;37(8):10177-85. doi: 10.1007/s13277-016-4883-7. Epub 2016 Jan 29.
9
MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.前列腺癌患者外周血中miR-139-5p水平升高。
Cell Physiol Biochem. 2016;39(3):1111-7. doi: 10.1159/000447819. Epub 2016 Aug 26.
10
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.miR-221 的表达在侵袭性前列腺癌和转移中逐渐降低,并可预测临床复发。
Int J Cancer. 2010 Jul 15;127(2):394-403. doi: 10.1002/ijc.24715.

引用本文的文献

1
Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation.紫檀芪对miR-20a的抑制作用通过上调NKG2D配体和下调TGF-β1促进自然杀伤细胞杀死前列腺癌细胞。
Heliyon. 2023 Mar 29;9(4):e14957. doi: 10.1016/j.heliyon.2023.e14957. eCollection 2023 Apr.
2
Dietary stilbenes as modulators of specific miRNAs in prostate cancer.作为前列腺癌中特定微小RNA调节剂的膳食芪类化合物。
Front Pharmacol. 2022 Aug 24;13:970280. doi: 10.3389/fphar.2022.970280. eCollection 2022.
3
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.
非编码RNA对前列腺癌神经内分泌样分化的调控
Noncoding RNA. 2021 Dec 2;7(4):75. doi: 10.3390/ncrna7040075.
4
miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression.微小RNA-148a、微小RNA-152和微小RNA-200b通过靶向DNA甲基转移酶1和磷酸酶及张力蛋白同源物的表达促进前列腺癌转移。
Oncol Lett. 2021 Nov;22(5):805. doi: 10.3892/ol.2021.13066. Epub 2021 Sep 23.
5
Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer-A Multi-Institutional Study.肿瘤上皮中miR-20a-5p的过表达是前列腺癌的独立阴性预后指标——一项多机构研究
Cancers (Basel). 2021 Aug 14;13(16):4096. doi: 10.3390/cancers13164096.
6
Overexpression of miR-20a promotes the progression of osteosarcoma by directly targeting QKI2.miR-20a的过表达通过直接靶向QKI2促进骨肉瘤进展。
Oncol Lett. 2019 Jul;18(1):87-94. doi: 10.3892/ol.2019.10313. Epub 2019 May 3.
7
Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer.循环miR-20a和miR-26a作为前列腺癌的生物标志物
Asian Pac J Cancer Prev. 2019 May 25;20(5):1453-1456. doi: 10.31557/APJCP.2019.20.5.1453.
8
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy.循环 miRNA 作为非侵入性生物标志物预测根治性前列腺切除术后侵袭性前列腺癌。
J Transl Med. 2019 May 23;17(1):173. doi: 10.1186/s12967-019-1920-5.
9
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
10
Modeling human prostate cancer progression in vitro.在体外模拟人类前列腺癌的进展。
Carcinogenesis. 2019 Jul 20;40(7):893-902. doi: 10.1093/carcin/bgy185.